Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Effects of chronic systemic low-impact ampakine treatment on neurotrophin expression in rat brain.

Radin DP, Johnson S, Purcell R, Lippa AS.

Biomed Pharmacother. 2018 Sep;105:540-544. doi: 10.1016/j.biopha.2018.06.008. Epub 2018 Jun 7.

PMID:
29886374
2.

Oncolytic Properties of Ampakines In Vitro.

Radin DP, Purcell R, Lippa AS.

Anticancer Res. 2018 Jan;38(1):265-269.

PMID:
29277782
3.

Animal tests of anxiety.

File SE, Lippa AS, Beer B, Lippa MT.

Curr Protoc Neurosci. 2004 May;Chapter 8:Unit 8.3. doi: 10.1002/0471142301.ns0803s26.

PMID:
18428606
4.

Characterization of the antinociceptive actions of bicifadine in models of acute, persistent, and chronic pain.

Basile AS, Janowsky A, Golembiowska K, Kowalska M, Tam E, Benveniste M, Popik P, Nikiforuk A, Krawczyk M, Nowak G, Krieter PA, Lippa AS, Skolnick P, Koustova E.

J Pharmacol Exp Ther. 2007 Jun;321(3):1208-25. Epub 2007 Feb 26.

PMID:
17325229
5.

The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors.

Popik P, Kostakis E, Krawczyk M, Nowak G, Szewczyk B, Krieter P, Chen Z, Russek SJ, Gibbs TT, Farb DH, Skolnick P, Lippa AS, Basile AS.

J Pharmacol Exp Ther. 2006 Dec;319(3):1244-52. Epub 2006 Sep 13.

PMID:
16971504
6.

Animal tests of anxiety.

File SE, Lippa AS, Beer B, Lippa MT.

Curr Protoc Pharmacol. 2005 Jan 1;Chapter 5:Unit 5.38. doi: 10.1002/0471141755.ph0538s27.

PMID:
22294128
7.

Anxioselective anxiolytics: can less be more?

Basile AS, Lippa AS, Skolnick P.

Eur J Pharmacol. 2004 Oct 1;500(1-3):441-51. Review.

PMID:
15464051
8.

"Broad spectrum" antidepressants: is more better for the treatment of depression?

Skolnick P, Popik P, Janowsky A, Beer B, Lippa AS.

Life Sci. 2003 Nov 7;73(25):3175-9. Review.

PMID:
14561522
9.

Antidepressant-like actions of DOV 21,947: a "triple" reuptake inhibitor.

Skolnick P, Popik P, Janowsky A, Beer B, Lippa AS.

Eur J Pharmacol. 2003 Feb 14;461(2-3):99-104.

PMID:
12586204
10.

Introduction. Overview of citalopram.

Lippa AS, Beer B, Cancro R.

J Clin Psychopharmacol. 1999 Oct;19(5 Suppl 1):1S-3S. No abstract available.

PMID:
10507504
11.

Effect of AL 721, a novel membrane fluidizer, on the binding parameters of brain dopamine receptors.

Antonian L, Lippa AS.

Ann N Y Acad Sci. 1988;515:403-10. No abstract available.

PMID:
3364897
12.

AL721, a novel membrane fluidizer.

Antonian L, Shinitzky M, Samuel D, Lippa AS.

Neurosci Biobehav Rev. 1987 Winter;11(4):399-413. Review.

PMID:
3325866
13.
14.
15.
16.

Effects of a novel compound (AL 721) on HTLV-III infectivity in vitro.

Sarin PS, Gallo RC, Scheer DI, Crews F, Lippa AS.

N Engl J Med. 1985 Nov 14;313(20):1289-90. No abstract available.

PMID:
2414659
17.

Assay of brain calmodulin levels using high-performance liquid chromatography.

Loullis CC, Antonian L, Rauh CE, Fliegner K, Coupet J, Lippa AS.

J Neurochem. 1985 Apr;44(4):1111-5.

PMID:
3973608
18.

Heterogeneity of brain benzodiazepine receptors: effects of physiological conditions.

Lippa AS, Garrett KM, Tabakoff B, Beer B, Wennogle LP, Meyerson LR.

Brain Res Bull. 1985 Feb;14(2):189-95.

PMID:
2986793
19.

Hippocampal muscarinic receptor loss following trimethyl tin administration.

Loullis CC, Dean RL, Lippa AS, Clody DE, Coupet J.

Pharmacol Biochem Behav. 1985 Jan;22(1):147-51.

PMID:
3975239
20.

Conformational changes in muscarinic receptors may produce diminished cholinergic neurotransmission and memory deficits in aged rats.

Lippa AS, Loullis CC, Rotrosen J, Cordasco DM, Critchett DJ, Joseph JA.

Neurobiol Aging. 1985 Winter;6(4):317-23.

PMID:
3003612
21.

Norepinephrine stimulation of phospholipid methylation in rat cortical synaptosomes: fact or artifact?

Wazer DE, Mandio Cordasco D, Segarnick DJ, Lippa AS, Meyerson LR, Benson D, Rotrosen J.

Life Sci. 1983 May 30;32(22):2535-44.

PMID:
6855456
22.

Chronic administration of cholinergic agents: effects on behavior and calmodulin.

Loullis CC, Dean RL, Lippa AS, Meyerson LR, Beer B, Bartus RT.

Pharmacol Biochem Behav. 1983 Apr;18(4):601-4.

PMID:
6867065
23.

The separation of 3H-benzodiazepine binding sites in brain and of benzodiazepine pharmacological properties.

Dubnick B, Lippa AS, Klepner CA, Coupet J, Greenblatt EN, Beer B.

Pharmacol Biochem Behav. 1983 Feb;18(2):311-8. Review.

PMID:
6132409
24.

Molecular substrates of anxiety: clues from the heterogeneity of benzodiazepine receptors.

Lippa AS, Meyerson LR, Beer B.

Life Sci. 1982 Oct 4;31(14):1409-17. Review. No abstract available.

PMID:
6292638
25.

The cholinergic hypothesis of geriatric memory dysfunction.

Bartus RT, Dean RL 3rd, Beer B, Lippa AS.

Science. 1982 Jul 30;217(4558):408-14. Review.

PMID:
7046051
26.

Human brain receptor alterations in suicide victims.

Meyerson LR, Wennogle LP, Abel MS, Coupet J, Lippa AS, Rauh CE, Beer B.

Pharmacol Biochem Behav. 1982 Jul;17(1):159-63.

PMID:
6289359
27.

The effects of acute administration of diazepam on the binding of [3H]-diazepam and [3H]-gaba to rat cortical membranes.

Coupet J, Rauh CE, Lippa AS, Beer B.

Pharmacol Biochem Behav. 1981 Dec;15(6):965-8.

PMID:
6275420
28.

Effect of acute and chronic pentylenetetrazol treatment on benzodiazepine and cholinergic receptor binding in rat brain.

Lal H, Mann PA Jr, Shearman GT, Lippa AS.

Eur J Pharmacol. 1981 Oct 22;75(2-3):115-9.

PMID:
6274662
29.

Dopamine receptor alterations with aging in mouse and rat corpus striatum.

Marquis JK, Lippa AS, Pelham RW.

Biochem Pharmacol. 1981 Jul 1;30(13):1876-8. No abstract available.

PMID:
6268112
30.

Differential ontogeny of type 1 and type 2 benzodiazepine receptors.

Lippa AS, Beer B, Sano MC, Vogel RA, Meyerson LR.

Life Sci. 1981 May 21;28(21):2343-7. No abstract available.

PMID:
6265728
31.

Synthesis and anxiolytic activity of 6-(substituted-phenyl)-1,2,4-triazolo[4,3-b]pyridazines.

Albright JD, Moran DB, Wright WB Jr, Collins JB, Beer B, Lippa AS, Greenblatt EN.

J Med Chem. 1981 May;24(5):592-600.

PMID:
6113284
32.

Lateral olfactory tract lesions reveal neuronal localization of benzodiazepine recognition sites.

Meyerson LR, Sano MC, Critchett DJ, Beer B, Lippa AS.

Eur J Pharmacol. 1981 Apr 24;71(1):147-50.

PMID:
6263648
33.

Multiple benzodiazepine receptor localization by light microscopic radiohistochemistry.

Young WS 3rd, Niehoff D, Kuhar MJ, Beer B, Lippa AS.

J Pharmacol Exp Ther. 1981 Feb;216(2):425-30.

PMID:
6257892
34.

Age-related alterations in neurotransmitter receptors: an electrophysiological and biochemical analysis.

Lippa AS, Critchett DJ, Ehlert F, Yamamura HI, Enna SJ, Bartus RT.

Neurobiol Aging. 1981 Spring;2(1):3-8. No abstract available.

PMID:
6115325
35.

Age-related changes in passive avoidance retention: modulation with dietary choline.

Bartus RT, Dean RL, Goas JA, Lippa AS.

Science. 1980 Jul 11;209(4453):301-3. No abstract available.

PMID:
7384805
36.

Brain cholinergic dysfunction and memory in aged rats.

Lippa AS, Pelham RW, Beer B, Critchett DJ, Dean RL, Bartus RT.

Neurobiol Aging. 1980 Summer;1(1):13-9.

PMID:
7266730
37.

Resolution of two biochemically and pharmacologically distinct benzodiazepine receptors.

Klepner CA, Lippa AS, Benson DI, Sano MC, Beer B.

Pharmacol Biochem Behav. 1979 Oct;11(4):457-62.

PMID:
523502
38.

A synthetic non-benzodiazepine ligand for benzodiazepine receptors: a probe for investigating neuronal substrates of anxiety.

Lippa AS, Coupet J, Greenblatt EN, Klepner CA, Beer B.

Pharmacol Biochem Behav. 1979 Jul;11(1):99-106.

PMID:
40260
39.

Benzodiazepine receptors: cellular and behavioral characteristics.

Lippa AS, Critchett D, Sano MC, Klepner CA, Greenblatt EN, Coupet J, Beer B.

Pharmacol Biochem Behav. 1979 May;10(5):831-43. Review.

PMID:
40258
40.

Endocrine factors contributing to the ethanol preferences of rodents.

Goas JA, Pelham RW, Lippa AS.

Pharmacol Biochem Behav. 1979 Apr;10(4):557-60.

PMID:
572551
41.

Relationship between benzodiazepine receptors and experimental anxiety in rats.

Lippa AS, Klepner CA, Yunger L, Sano MC, Smith WV, Beer B.

Pharmacol Biochem Behav. 1978 Dec;9(6):853-6.

PMID:
34175
42.

Enhancement of 3H-diazepam binding by SQ 65,396: a novel anti-anxiety agent.

Beer B, Klepner CA, Lippa AS, Squires RF.

Pharmacol Biochem Behav. 1978 Dec;9(6):849-51.

PMID:
34174
43.

Evidence that benzodiazepine receptors reside on cerebellar purkinje cells: studies with "nervous" mutant mice.

Lippa AS, Sano MC, Coupet J, Klepner CA, Beer B.

Life Sci. 1978 Nov 27;23(22):2213-7. No abstract available.

PMID:
723473
44.

Bimodal distributions of highest ethanol acceptance concentrations in two strains of rats.

Goas JA, Lippa AS.

Pharmacol Biochem Behav. 1978 Jun;8(6):695-9.

PMID:
693554
45.

The neuropharmacological actions of amoxapine.

Greenblatt EN, Lippa AS, Osterberg AC.

Arch Int Pharmacodyn Ther. 1978 May;233(1):107-35.

PMID:
28699
46.

Additional studies on the importance of glycine and GABA in mediating the actions of benzodiazepines.

Lippa AS, Regan B.

Life Sci. 1977 Dec 15;21(12):1779-83. No abstract available.

PMID:
604705
47.

Effects of clozapine, chlorpromazine and diazepam upon adjunctive and schedule controlled behaviors.

Canon JG, Lippa AS.

Pharmacol Biochem Behav. 1977 May;6(5):581-7.

PMID:
896893
48.

Use of DRL in differentiating anxiolytic and neuroleptic properties of CNS drugs.

Canon JG, Lippa AS.

Pharmacol Biochem Behav. 1977 May;6(5):591-3.

PMID:
19772
49.

Effects of 6-hydroxydopamine on body weight: feeding deficits or sensory-motor impairments?

Pelham RW, Lippa AS, Sano MC.

Commun Psychopharmacol. 1977;1(6):553-63. No abstract available.

PMID:
608325
50.

Relationship between catecholamines and ACTH: effects of 6-hydroxy-dopamine.

Lippa AS, Antelman SM, Fahringer EE, Redgate ES.

Nat New Biol. 1973 Jan 3;241(105):24-5. No abstract available.

PMID:
4349155

Supplemental Content

Loading ...
Support Center